The annual J.P. Morgan Healthcare Conference, often called the Superbowl of biotech, kicked off on Jan. 8, 2018.
Over 450 companies will be presenting, including Celgene (NASDAQ:CELG), Pfizer (NYSE:PFE), and Johnson & Johnson (NYSE:JNJ), and over 9,000 people (including The Motley Fool's Kristine Harjes) will be attending. But don't worry -- The Motley Fool's healthcare team will keep you informed about the most important announcements and analysis. Check back daily for updates!
- 4 Ways IBM Watson's Artificial Intelligence Is Changing Healthcare
- Here's Why Arrowhead Pharmaceuticals Inc. Is Up Today
- 7 Must-See Numbers From AbbVie's J. P. Morgan Presentation
- Rite Aid Is Outperforming the S&P 500 So Far in 2018: Here Are 5 Reasons Why
- Eli Lilly & Co. at JP Morgan: 5 Things Investors Will Want to Know
- Here's Why Novavax, Inc. Stock Shot Up Today
- Bill Gates Speaks Out on the State of Global Healthcare
- 3 Slides That Paint a Great Picture for Exact Sciences' Future
- 3 Keys for Acadia Pharmaceuticals to Succeed in 2018
- 5 Things Amgen's CEO Just Said That Investors Need to Know
- 5 Ways Gilead Sciences Plans to Return to Growth
- 5 Reasons Illumina Enjoyed a Big J.P. Morgan Conference Bounce
- Johnson & Johnson Wants to Create a Crisis -- and That's Great for Investors
- 5 Things You Need to Know From Celgene's J.P. Morgan Presentation
- 10 Things to Expect From Vertex Pharmaceuticals in 2018
- The 1 Word That Explains Why Pfizer's Future Looks Brighter Than Its Past
- Why Exact Sciences Is Tumbling Today
P.S. If you're interested in checking out how much things have changed since this time in 2017, here's last year's landing page.
Kristine Harjes owns shares of Gilead Sciences and Johnson & Johnson. The Motley Fool owns shares of and recommends Celgene, Gilead Sciences, Illumina, and Johnson & Johnson. The Motley Fool recommends Vertex Pharmaceuticals. The Motley Fool has a disclosure policy.